全文获取类型
收费全文 | 1279篇 |
免费 | 74篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 41篇 |
妇产科学 | 5篇 |
基础医学 | 139篇 |
口腔科学 | 28篇 |
临床医学 | 136篇 |
内科学 | 188篇 |
皮肤病学 | 10篇 |
神经病学 | 92篇 |
特种医学 | 33篇 |
外科学 | 332篇 |
综合类 | 17篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 106篇 |
眼科学 | 26篇 |
药学 | 95篇 |
中国医学 | 36篇 |
肿瘤学 | 67篇 |
出版年
2024年 | 3篇 |
2023年 | 13篇 |
2022年 | 23篇 |
2021年 | 59篇 |
2020年 | 33篇 |
2019年 | 60篇 |
2018年 | 52篇 |
2017年 | 32篇 |
2016年 | 39篇 |
2015年 | 42篇 |
2014年 | 47篇 |
2013年 | 64篇 |
2012年 | 99篇 |
2011年 | 86篇 |
2010年 | 50篇 |
2009年 | 55篇 |
2008年 | 101篇 |
2007年 | 101篇 |
2006年 | 75篇 |
2005年 | 49篇 |
2004年 | 60篇 |
2003年 | 45篇 |
2002年 | 49篇 |
2001年 | 9篇 |
2000年 | 13篇 |
1999年 | 10篇 |
1998年 | 12篇 |
1997年 | 8篇 |
1996年 | 2篇 |
1995年 | 4篇 |
1994年 | 4篇 |
1993年 | 9篇 |
1992年 | 2篇 |
1991年 | 4篇 |
1990年 | 4篇 |
1989年 | 4篇 |
1987年 | 2篇 |
1986年 | 2篇 |
1984年 | 2篇 |
1983年 | 2篇 |
1981年 | 3篇 |
1980年 | 4篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1974年 | 5篇 |
1973年 | 2篇 |
1970年 | 1篇 |
1965年 | 1篇 |
1960年 | 1篇 |
1959年 | 2篇 |
排序方式: 共有1356条查询结果,搜索用时 15 毫秒
41.
42.
43.
Tahir Naeem Khan J. Klar Zafar Ali F. Khan S.M. Baig N. Dahl 《European journal of medical genetics》2013,56(7):371-374
Cenani–Lenz syndrome (CLS) is a rare autosomal recessive developmental disorder of the limbs. The disorder is characterized by complete syndactyly with metacarpal fusions and/or oligodactyly sometimes accompanied by radioulnar synostosis. The clinical expression is variable and kidney agenesis/hypoplasia, craniofacial dysmorphism and teeth abnormalities are frequent features as well as lower limb involvement. CLS was recently associated with mutations in the low-density lipoprotein receptor-related protein 4 (LRP4) gene and dysregulated canonical WNT signaling. We have identified a large consanguineous Pakistani pedigree with 9 members affected by CLS. The affected individuals present with a consistent expression of the syndrome restricted to the limbs and kidneys. Symptoms from the lower limb are mild or absent and there were no radioulnar synostosis or craniofacial involvement. Genetic analysis using autozygosity mapping and sequencing revealed homozygosity for a novel missense mutation c.2858T > C (p.L953P) in the LRP4 gene. The mutation is located in a region encoding the highly conserved low-density lipoprotein receptor repeat class B domain of LRP4. Our findings add to the genotype–phenotype correlations in CLS and support kidney anomalies as a frequent associated feature. 相似文献
44.
45.
Deipanjan Nandi Kimberly Y. Lin Matthew J. O’Connor Okan U. Elci Jeffrey J. Kim Jamie A. Decker Jack F. Price Farhan Zafar David L. S. Morales Susan W. Denfield William J. Dreyer John L. Jefferies Joseph W. Rossano 《Pediatric cardiology》2016,37(3):512-518
Scarce data exist regarding costs of pediatric heart failure-related hospitalizations (HFRH) or how costs have changed over time. Pediatric HFRH costs, due to advances in management, will have increased significantly over time. A retrospective analysis of Healthcare Cost and Utilization Project Kids’ Inpatient Database was performed on all pediatric HFRH. Inflation-adjusted charges are used as a proxy for cost. There were a total of 33,189 HFRH captured from 2000 to 2009. Median charges per HFRH rose from $35,079 in 2000 to $72,087 in 2009 (p < 0.0001). The greatest median charges were incurred in patients on extracorporeal membrane oxygenation ($442,134 vs $53,998) or ventricular assist devices ($462,647 vs $55,151). Comorbidities, including sepsis ($207,511 vs $48,995), renal failure ($180,624 vs $52,812), stroke ($198,260 vs $54,974) and respiratory failure ($146,200 vs $48,797), were associated with greater charges (p < 0.0001). Comorbidities and use of mechanical support increased over time. After adjusting for these factors, later year remained associated with greater median charges per HFRH (p < 0.0001). From 2000 to 2009, there has been an almost twofold increase in pediatric HFRH charges, after adjustment for inflation. Although comorbidities and use of mechanical support account for some of this increase, later year remained independently associated with greater charges. Further study is needed to understand potential factors driving these higher costs over time and to identify more cost-effective therapies in this population. 相似文献
46.
47.
48.
Shariq Najeeb Muhammad Sohail Zafar Zohaib Khurshid Sana Zohaib Sreenath Arekunnath Madathil Maria Mali Khalid Almas 《Saudi Pharmaceutical Journal》2018,26(5):634-642
Periodontitis is characterized by inflammation of the periodontium and leads to loss of teeth if untreated. Although a number of surgical and pharmacological options are available for the management of periodontitis, it still affects a large proportion of population. Recently, metformin (MF), an oral hypoglycemic, has been used to treat periodontitis. The aim of this review is to systematically evaluate the efficacy of MF in the treatment of periodontitis. An electronic search was carried out using the keywords ‘metformin’, ‘periodontal’ and ‘periodontitis’ via the PubMed/Medline, ISI Web of Science and Google Scholar databases for relevant articles published from 1949 to 2016. The addressed focused question was: ‘Is metformin effective in reducing bone loss in periodontitis? Critical review and meta-analysis were conducted of the results obtained in the selected studies. Following the removal of the duplicate results, the primary search resulted in 17 articles and seven articles were excluded based on title and abstract. Hence, 10 articles were read completely for eligibility. After exclusion of four irrelevant studies, six articles were included. The topical application of MF resulted in improved histological, clinical and radiographic outcomes. Additionally, results from the meta-analysis indicated that application of metformin improved the clinical and radiographic outcomes of scaling and root-planing, but at the same time heterogeneity was evident among the results. However, because of a lack of histological and bacterial studies, in addition to short follow-up periods and risk of bias, the long-term efficacy of MF in the treatment of bony defects is not yet ascertained. Further studies are needed to envisage the long-term efficacy of MF in the management of periodontitis. 相似文献
49.
Rajnish S. Dave Ravi K. Sharma Roshell R. Muir Elias Haddad Sanjeev Gumber Francois Villinger Artinder P. Nehra Zafar K. Khan Brian Wigdahl Aftab A. Ansari Siddappa N. Byrareddy Pooja Jain 《Journal of neuroimmune pharmacology》2018,13(2):204-218
Cerebrospinal fluid (CSF) drains via the lymphatic drainage pathway. This lymphatic pathway connects the central nervous system (CNS) to the cervical lymph node (CLN). As the CSF drains to CLN via the dural and nasal lymphatics, T cells and antigen presenting cells pass along the channels from the subarachnoid space through the cribriform plate. Human immunodeficiency virus (HIV) may also egress from the CNS along this pathway. As a result, HIV egressing from the CNS may accumulate within the CLN. Towards this objective, we analyzed CLNs isolated from rhesus macaques that were chronically-infected with simian immunodeficiency virus (SIV). We detected significant accumulation of SIV within the CLNs. SIV virion trapping was observed on follicular dendritic cells (FDCs) localized within the follicular regions of CLNs. In addition, SIV antigens formed immune complexes when FDCs interacted with B cells within the germinal centers. Subsequent interaction of these B cells with CD4+ T follicular helper cells (TFHs) resulted in infection of the latter. Of note, 73% to 90% of the TFHs cells within CLNs were positive for SIV p27 antigen. As such, it appears that not only do the FDCs retain SIV they also transmit them (via B cells) to TFHs within these CLNs. This interaction results in infection of TFHs in the CLNs. Based on these observations, we infer that FDCs within the CLNs have a novel role in SIV entrapment with implications for viral trafficking. 相似文献
50.
Jose Antonio Camacho-Conde Maria del Rosario Gonzalez-Bermudez Marta Carretero-Rey Zafar U. Khan 《CNS Neuroscience & Therapeutics》2022,28(1):5-18
Brain stimulation has become one of the most acceptable therapeutic approaches in recent years and a powerful tool in the remedy against neurological diseases. Brain stimulation is achieved through the application of electric currents using non-invasive as well as invasive techniques. Recent technological advancements have evolved into the development of precise devices with capacity to produce well-controlled and effective brain stimulation. Currently, most used non-invasive techniques are repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS), whereas the most common invasive technique is deep brain stimulation (DBS). In last decade, application of these brain stimulation techniques has not only exploded but also expanded to wide variety of neurological disorders. Therefore, in the current review, we will provide an overview of the potential of both non-invasive (rTMS and tDCS) and invasive (DBS) brain stimulation techniques in the treatment of such brain diseases. 相似文献